Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?
Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB
Management of EGFR Mutant NSCLC Patients and Future Directions (excluding Resistance to EGFR TKIs)
Roy S. Herbst, MD, PhD, FACP, FASCO
Neurological Complications and Management in the Era of Checkpoint Inhibitors
Michael T. Pulley, MD, PhD
